Bernstein Harold: insider trades.
Bernstein Harold reported 13 non-derivative transactions on 5 SEC ownership filings in Q3 2026: 0 open-market purchases and 9 sales ($1.8M), across 1 company.
- Transactions
- 13
- Purchases (P)
- 0
- Sales (S)
- 9
- Companies
- 1
- Name as filed
- Bernstein Harold
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Maze Therapeutics, Inc. (MAZE) | Officer · President, R&D & CMO | 13 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-04 | Maze Therapeutics, Inc. | S | 9,705 | $26.22 | 0 | Form 4 |
| 2026-09-03 | Maze Therapeutics, Inc. | S | 59 | $25.78 | 9,705 | Form 4 |
| 2026-09-03 | Maze Therapeutics, Inc. | S | 5,130 | $26.01 | 9,764 | Form 4 |
| 2026-09-02 | Maze Therapeutics, Inc. | S | 625 | $27.12 | 14,894 | Form 4 |
| 2026-09-02 | Maze Therapeutics, Inc. | S | 4,481 | $26.38 | 15,519 | Form 4 |
| 2026-09-01 | Maze Therapeutics, Inc. | M | 16,141 | $10.42 | 16,141 | Form 4 |
| 2026-09-01 | Maze Therapeutics, Inc. | S | 16,141 | $26.36 | 0 | Form 4 |
| 2026-09-01 | Maze Therapeutics, Inc. | M | 20,000 | $0 | 20,000 | Form 4 |
| 2026-08-13 | Maze Therapeutics, Inc. | S | 16,142 | $27.61 | 0 | Form 4 |
| 2026-08-13 | Maze Therapeutics, Inc. | M | 16,142 | $10.42 | 16,142 | Form 4 |
| 2026-07-01 | Maze Therapeutics, Inc. | S | 1,200 | $30.34 | 0 | Form 4 |
| 2026-07-01 | Maze Therapeutics, Inc. | M | 14,609 | $10.42 | 14,609 | Form 4 |
| 2026-07-01 | Maze Therapeutics, Inc. | S | 13,409 | $29.87 | 1,200 | Form 4 |
Questions
What stock did Bernstein Harold buy or sell?
Bernstein Harold reported 13 non-derivative transactions on 5 SEC ownership filings in Q3 2026: 0 open-market purchases and 9 sales ($1.8M), across 1 company.
Is Bernstein Harold the same person as other filers with this name?
This page covers SEC CIK 2050172 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/bernstein-harold-2050172.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.